Home/Filings/4/0001123292-19-001106
4//SEC Filing

Bertolino Arthur Peter 4

Accession 0001123292-19-001106

CIK 0001355250other

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 4:51 PM ET

Size

4.7 KB

Accession

0001123292-19-001106

Insider Transaction Report

Form 4
Period: 2019-09-01
Bertolino Arthur Peter
Pres. & Chief Medical Officer
Transactions
  • Tax Payment

    Class A Common Stock

    2019-09-01$0.13/sh421,611$54,8092,059,316 total

Issuer

Innovation Pharmaceuticals Inc.

CIK 0001355250

Entity typeother

Related Parties

1
  • filerCIK 0001426344

Filing Metadata

Form type
4
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 4:51 PM ET
Size
4.7 KB